Announce Date | 09/15/2025 |
EPS Normalized Actual | $0.11 (Beat by $0.02) |
EPS GAAP Actual | $0.11 (Beat by $0.02) |
Revenue Actual | $0.0070648B |
Revenue Surprise | Beat by $7.0648M |
Announce Date | 10/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.12 |
EPS GAAP Estimate | $0.12 |
Revenue Estimate | $0.006919B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2027 | 0.52 | 17.38 | 0.52 | 0.52 | 1 |
Oct 2025 | 0.54 | 16.74 | 0.54 | 0.54 | -1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2025 (Jul 2025) | 0.11 | -0.01 | 0.0070648B | 22.48% | 0.23M |
FQ2 2025 (Apr 2025) | 0.08 | -0.03 | 0.00701746B | 24.14% | 0.73M |
FQ1 2025 (Jan 2025) | 0.0814 | -0.0086 | 0.00520972B | 14.37% | -0.56M |
FQ4 2024 (Oct 2024) | 0.0292 | 0.0292 | 0.00505525B | 29.5% | 5.06M |
FQ3 2024 (Jul 2024) | 0.11 | 0.11 | 0.00547654B | 10.7% | 5.48M |
FQ2 2024 (Apr 2024) | 0.13 | 0.13 | 0.00532318B | 0.41% | 5.32M |
FQ1 2024 (Jan 2024) | 0.0566 | 0.0566 | 0.00446119B | -25.44% | 4.46M |
FQ4 2023 (Oct 2023) | 0 | 0 | 0.00356376B | -44.1% | 3.56M |
FQ4 Announce Date
10/30/2025 (Pre-Market)
Consensus EPS Estimates
0.12
Consensus Revenue Estimates
0.006919B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 0.16 | -- | 0.16 | 0.16 | 1 |
FQ2 2027 (Apr 2027) | 0.16 | -- | 0.16 | 0.16 | 1 |
FQ1 2027 (Jan 2027) | 0.07 | -- | 0.07 | 0.07 | 1 |
FQ4 2026 (Oct 2026) | 0.15 | -- | 0.15 | 0.15 | 1 |
FQ3 2026 (Jul 2026) | 0.16 | 31.25 | 0.16 | 0.16 | 1 |
FQ2 2026 (Apr 2026) | 0.11 | 27.27 | 0.11 | 0.11 | 1 |
FQ1 2026 (Jan 2026) | 0.08 | -1.75 | 0.08 | 0.08 | 1 |
FQ4 2025 (Oct 2025) | 0.12 | 75.67 | 0.12 | 0.12 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ2 2027 (Apr 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ1 2027 (Jan 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ4 2026 (Oct 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ3 2026 (Jul 2026) | 0.01B | 12.76 | 0.01B | 0.01B | 1 |
FQ2 2026 (Apr 2026) | 0.01B | 1.12 | 0.01B | 0.01B | 1 |
FQ1 2026 (Jan 2026) | 0.01B | 21.76 | 0.01B | 0.01B | 1 |
FQ4 2025 (Oct 2025) | 0.01B | 26.94 | 0.01B | 0.01B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | 0.12 | 0.11 | -0.01 | -9.09% |
FQ2 2025 (Apr 2025) | 0.11 | 0.08 | -0.03 | -37.5% |
FQ1 2025 (Jan 2025) | 0.09 | 0.0814 | -0.0086 | -10.57% |
FQ4 2024 (Oct 2024) | 0.0292 | 0.0292 | 100% | |
FQ3 2024 (Jul 2024) | 0.11 | 0.11 | 100% | |
FQ2 2024 (Apr 2024) | 0.13 | 0.13 | 100% | |
FQ1 2024 (Jan 2024) | 0.0566 | 0.0566 | 100% | |
FQ4 2023 (Oct 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | $0.01B | $0.01B | $0.23M | 3.27% |
FQ2 2025 (Apr 2025) | $0.01B | $0.01B | $0.73M | 10.41% |
FQ1 2025 (Jan 2025) | $0.01B | $0.01B | $-0.56M | -10.7% |
FQ4 2024 (Oct 2024) | $0B | $0.01B | $5.06M | 100% |
FQ3 2024 (Jul 2024) | $0B | $0.01B | $5.48M | 100% |
FQ2 2024 (Apr 2024) | $0B | $0.01B | $5.32M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0B | $4.46M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0B | $3.56M | 100% |